Insider Trading activities at Health Sciences Group Inc (HESG.OB)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Health Sciences Group Inc (HESG.OB) since 2007 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Health Sciences Group Inc. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 1127696.

Total stock buying since 2007: $0.
Total stock sales since 2007: $18,840.
Total stock option exercises since 2007: $0.

▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies


Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Health Sciences Group Inc (HESG.OB).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2007 0 $0 942,000 $18,840 0 $0

Table 2. Monthly summary of insider trading at Health Sciences Group Inc (HESG.OB).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2007-02 0 $0 942,000 $18,840 0 $0

Table 3. Detailed insider trading at Health Sciences Group Inc (HESG.OB)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2007-02-23 Utek Corp (10% Owner) Sale 100,000 .02 2,000
2007-02-22 Utek Corp (10% Owner) Sale 100,000 .02 2,000
2007-02-14 Utek Corp (10% Owner) Sale 200,000 .02 4,000
2007-02-13 Utek Corp (10% Owner) Sale 100,000 .02 2,000
2007-02-12 Utek Corp (10% Owner) Sale 50,000 .02 1,000
2007-02-09 Utek Corp (10% Owner) Sale 50,000 .02 1,000
2007-02-08 Utek Corp (10% Owner) Sale 100,000 .02 2,000
2007-02-07 Utek Corp (10% Owner) Sale 242,000 .02 4,840

Insider trading activities including stock purchases, stock sales, and option exercises of HESG.OB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Health Sciences Group Inc (symbol HESG.OB, CIK number 1127696) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.